Search Results for 'taf study'

taf study published presentations and documents on DocSlides.

Ysgol Coedcae School Team around the family (TAF)

Ysgol Coedcae School Team around the family (TAF)

by tawny-fly

School context. Mixed, 11-16 comprehensive, urban...

Switch from TDF to TAF

Switch from TDF to TAF

by easyho

GS-US-292-0109 Study. GS-US-311-1089 Study. . De...

Tenofovir Alafenamide (TAF)

Tenofovir Alafenamide (TAF)

by nicole

in a Single-Tablet Regimen . in Initial HIV-1 Ther...

Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection

Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection

by melanie

Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV...

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

by iris

ADVANCE. . Design. Primary endpoint. Proportion ...

Switch to E/C/F/TAF + DRV

Switch to E/C/F/TAF + DRV

by lindy-dunigan

Study GS-US-292-0119. E/C/F/TAF + DRV 800 mg QD. ...

Switching to Bictegravir

Switching to Bictegravir

by emery

/. Emtricitabine. /. Tenofovir. . Alafenamide. (...

Brad Hare Nothing to Disclose

Brad Hare Nothing to Disclose

by beatrice

Kaiser Permanente San Francisco Medical Center. Sa...

Any PRM at baseline Yes No

Any PRM at baseline Yes No

by lucy

39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

by lam

Endpoints. Primary: proportion of patients with HI...

Phase 2 of new ARVs Fostemsavir

Phase 2 of new ARVs Fostemsavir

by sportyinds

, . prodrug. of . temsavir. . (. attachment inhi...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

by mediumgeneral

QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...

by lindy-dunigan

from. TDF to TAF. GS-US-292-0109 Study. GS-US-31...

HIV 2015-2016: New Agents, New Strategies

HIV 2015-2016: New Agents, New Strategies

by ellena-manuel

Learning Objectives. EARLY VS DEFERRED ART. The C...

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

by micah

Tenofovir. . Disoproxil. . Fumarate. to . Tenof...

Last name First

Last name First

by ash

nameBirth place BirthdatePermanent residence addre...

GS-US-380-1878 GS-US-380-1844

GS-US-380-1878 GS-US-380-1844

by phoebe

GS-US-380-1961. . Switch to BIC/FTC/TAF. Design...

Stephanie Cox Gilead Sciences

Stephanie Cox Gilead Sciences

by emery

Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

by scarlett

Judith S. Currier, MD, MSc. Professor of Medicine....

Safety of Tenofovir

Safety of Tenofovir

by deandre922

Alafenamide. in Renal Impairment. A Pozniak. 1. ,...